Protagonist Therapeutics, Inc. (PTGX)
83.32
-1.17
(-1.38%)
USD |
NASDAQ |
Feb 09, 16:00
83.18
-0.14
(-0.17%)
After-Hours: 20:00
Protagonist Therapeutics EPS Diluted (Quarterly) : -0.6169 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ADMA Biologics, Inc. | 0.1489 |
| Johnson & Johnson | 2.098 |
| Glaukos Corp. | -0.2828 |
| Krystal Biotech, Inc. | 2.660 |
| TransMedics Group, Inc. | 0.6601 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -39.34M |
| Revenue (Quarterly) | 4.712M |
| Total Expenses (Quarterly) | 44.05M |
| Enterprise Value | 4.643B |
| Gross Profit Margin (Quarterly) | 92.34% |
| Profit Margin (Quarterly) | -834.9% |
| Earnings Yield | 0.76% |
| Operating Earnings Yield | 0.36% |
| Normalized Earnings Yield | 0.7601 |